The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADVANTAGE SOLUTIONS INC | COM CL A | 00791N102 | 9,305,800 | 2,890,000 | SH | SOLE | 2,890,000 | 0 | 0 | ||
| AVEANNA HEALTHCARE HLDGS INC | COM | 05356F105 | 225,218,429 | 81,600,880 | SH | SOLE | 81,600,880 | 0 | 0 | ||
| CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 2,685,646,245 | 65,679,781 | SH | SOLE | 65,679,781 | 0 | 0 | ||
| SURGERY PARTNERS INC | COM | 86881A100 | 1,188,238,464 | 49,946,972 | SH | SOLE | 49,946,972 | 0 | 0 | ||
| WAYSTAR HLDG CORP | COM | 946784105 | 601,578,966 | 27,980,417 | SH | SOLE | 27,980,417 | 0 | 0 | ||